Semaglutide is a GLP-1 receptor agonist originally developed for type 2 diabetes and now widely prescribed for weight management. It works by mimicking the incretin hormone GLP-1, reducing appetite, slowing gastric emptying, and improving insulin sensitivity.
At Healtrix, semaglutide is prescribed only after comprehensive metabolic assessment including HbA1c, fasting insulin, lipid panel, and liver function tests. We start at a low dose and titrate gradually to minimise gastrointestinal side effects.
Ongoing monitoring includes monthly check-ins, quarterly blood work, and body composition tracking. Our goal is sustainable metabolic optimisation, not rapid weight loss.
Monthly supply · Metabolic